Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area proteases calpains'

Search results for: 'research area proteases calpains'

Items 1-10 of 60

Page
per page
  1. Calpain Inhibitor I, ALLN
    A2602 Calpain Inhibitor I, ALLN
     2 Citation
    Target: Cathepsins|Calpains
    Summary: Calpain I/II/ B/L inhibitor
  2. MDL 28170
    A4412 MDL 28170
    Target: Cathepsins|Calpains
    Summary: Calpain and cathepsin B inhibitor, selective
      insoluble in H2O; ≥16.75 mg/mL
  3. PD 150606
    A4413 PD 150606
    Target: Calpains
    Summary: Non-peptide calpain inhibitor
      Soluble in DMSO
  4. E-64
    A2576 E-64
     2 Citation
    Target: Cathepsins|Calpains|Papains
    Summary: Cysteine protease inhibitor,irriversible
      ≥49.1 mg/mL
  5. MG-132
    A2585 MG-132
     26 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor, Cell permeable, reversible
      ≥23.78 mg/mL
  6. Leupeptin, Microbial
    A2570 Leupeptin, Microbial
    Target: Cathepsins|Calpains|Trypsins
    Summary: Inhibitor of serine and cysteine proteases
      ≥24.7 mg/mL
  7. Amprenavir (agenerase)
    A8201 Amprenavir (agenerase)
    Summary: HIV-1 protease inhibitor
  8. Lopinavir
    A8204 Lopinavir
    Summary: HIV protease inhibitor,highly potent
      ≥31.45 mg/mL
  9. Atazanavir
    A8205 Atazanavir
     1 Citation
    Summary: HIV protease inhibitor,highly potent
      ≥28.6 mg/mL
  10. Saquinavir mesylate
    A3791 Saquinavir mesylate
    Summary: HIV Protease Inhibitor

Items 1-10 of 60

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 46item
  2. Metabolism 9item
  3. DNA Damage/DNA Repair 1 item
  4. Microbiology & Virology 7item
  5. Ubiquitination/ Proteasome 14item
  6. Angiogenesis 1 item
  7. Neuroscience 1 item
Reversibility
  1. Reversible 9item
  2. Irreversible 6item
Target
  1. Proteasome 9item
  2. Cathepsins 11item
  3. MMP 3item
  4. Thymidylate Synthase 1 item
  5. Deubiquitinating enzymes (DUBs) 1 item
  6. Aminopeptidases 2item
  7. HSP90 4item
  8. Renin 1 item
  9. HIV proteases 1 item
  10. Pepsins 1 item
  11. Calpains 5item
  12. Ubiquitin-specific proteases 1 item
  13. HCV Proteases 2item
  14. Trypsins 1 item
  15. Trypsin 1 item
  16. Chymotrypsin 1 item
  17. Kallikrein 1 item
  18. Trypsinogen 1 item
  19. HIV-1 gp120 1 item
  20. Fatty-acid-binding proteins (FABPs) 1 item
  21. 20S proteasomal chymotrypsin 1 item
  22. Geranylgeranyltransferase I 1 item
  23. Farnesyltransferase 1 item
  24. IL Receptors 1 item
  25. CCL2 1 item
  26. Papains 1 item
  27. DPP-4 3item
  28. ADAMs 1 item
  29. PAR 1 item
  30. Elastases 1 item
Reported Experiments
  1. Animal Experiments 57item
  2. Cell Experiments 39item
Related Disease
  1. Acute Lung Injury 1 item
  2. Breast Cancer 8item
  3. Cancer 26item
  4. Colon Cancer 3item
  5. Colon Carcinoma 1 item
  6. Colorectal Cancer 1 item
  7. Diabetes 3item
  8. Glioma 1 item
  9. HCV 1 item
  10. Hepatitis C 1 item
  11. HIV 1 item
  12. HIV Infections 1 item
  13. Inflammatory Diseases 1 item
  14. Leukemia 1 item
  15. Lung Cancer 1 item
  16. Lymphoma 1 item
  17. Mantle Cell Lymphoma 1 item
  18. Melanoma 3item
  19. Multiple Myeloma 4item
  20. Myeloma 2item
  21. Neuroblastoma 1 item
  22. Non-small Cell Lung Cancer 3item
  23. Osteoporosis 1 item
  24. Ovarian Cancer 3item
  25. Pancreatic Cancer 2item
  26. Prostate Cancer 2item
  27. Psoriasis 1 item
  28. Renal Cell Carcinoma 1 item
  29. Rheumatoid Arthritis 2item
  30. Squamous Cell Carcinoma 1 item
  31. Type 2 Diabetes 1 item